Navigation Links
NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
Date:12/12/2010

reast to distant sites in the body.  

Anthracyclines and taxanes (AT) are the most active and widely used chemotherapeutic agents for breast cancer, but the increased use of these agents at an early stage of disease often renders tumors resistant to these drugs by the time the disease recurs, thereby reducing the number of treatment options for metastatic disease.  Drugs used to treat patients who progress following AT treatment can be as high as 20-30%; however, resistance develops rapidly and new agents with different mechanisms of action, such as topoisomerase I inhibitors, are needed to allow novel ways to overcome the problem of drug resistance.(2)  There are currently no FDA-approved topoisomerase I inhibitors to treat breast cancer.

About NKTR-102 Nektar is developing NKTR-102, a topoisomerase I inhibitor-polymer conjugate with reduced peak concentrations and a continuous concentration profile.  NKTR-102 was invented by Nektar using its advanced polymer conjugate technology platform, and is the first oncology product candidate to leverage Nektar's releasable polymer technology platform.  

In addition to the fully-enrolled Phase 2 studies in platinum-refractory/resistant ovarian cancer and metastatic breast cancer, NKTR-102 is also being tested in a separate Phase 2 clinical trial in patients with second-line colorectal cancer and a Phase 1 clinical trial evaluating NKTR-102 in combination with 5-FU therapy.  An expansion arm of the Phase 2 study of single-agent NKTR-102 in platinum-refractory/resistant ovarian cancer in women who failed prior Doxil therapy is also currently enrolling.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms.  Nektar's technology and drug development expertise have enabled nine approved products in the U.S. or Europe for leading biopharmaceutical
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
2. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
3. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
4. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
5. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
6. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
7. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
10. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
11. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ... on China,s Sodium Ibandronate Market, 2010-2019" report to their ... under the trade name of Bondronat in Germany ... sodium ibandronate was approved by the FDA to come into ... trade name of Boniva. However, since drug makers later developed ...
(Date:9/4/2015)... 4, 2015 Hutchison China ... Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, ... proof-of-concept ("POC") trial of fruquintinib in patients with ... China .  The top-line results ... the primary efficacy endpoint of progression free survival ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... N.J., April 25, 2011 MonoSol Rx, LLC ... technology, today announced that the Company has entered ... a biopharmaceutical company focused on the discovery and ... of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular ...
... SynapDx Corporation announced today that Thomas Mac ... Thomas Mac Mahon was President and Chief Executive Officer and ... Corporation of America (LabCorp) from January 1997 until his retirement ... Mahon was Senior Vice President of Hoffmann-La Roche Inc. (Roche) ...
Cached Medicine Technology:MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD 2MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD 3MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD 4
(Date:9/4/2015)... ... September 04, 2015 , ... Steven Winter Associates, ... Connecticut, has been selected for the Residential Award of Merit by the Connecticut ... measures. Chosen from a highly competitive field of submissions, the net-zero energy residence ...
(Date:9/4/2015)... Texas (PRWEB) , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... he says are prophetic details involving the Pope’s upcoming trip to the United States. , ... details what his role with the Vatican and society is. Yisrayl also provides the meaning ...
(Date:9/4/2015)... ... September 04, 2015 , ... EMED Jamaica Global Ltd. ... it has entered into a multi-year agreement with Health City Cayman Islands. , ... link between American healthcare, Jamaican healthcare and Health City Cayman Islands to deliver ...
(Date:9/3/2015)... ... September 04, 2015 , ... AlignLife of Wauwatosa is ... "There are so many children and adults who don't have the ability to buy ... "We love holding our annual Coat Drive to help those in need." , This ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce a ... norm not the exception. , St. Jude was recently named one of the nation’s ... making it one of only 10 hospitals in the state to earn the distinction. ...
Breaking Medicine News(10 mins):Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... be held May 13th at Long Beach Veterans ... The West Hills/Northridge,Veterans Administration will honor Dr. ... contributions to the health of American,war veterans. The ... is conducting a clinical research study aimed at,examining ...
... Council(R) Applauds Enactment of Safety of Seniors Act, ... only,national nonprofit organization solely dedicated to preventing,unintentional home injuries, ... bill, signed into law by President Bush yesterday, comes,at ... Americans age 65 and older,falls and about 30 percent ...
... arrive quickly at the scene to save people and property, ... of an infection promptly to mount a protective response. , ... specialized types of white blood cells, a category called regulatory ... a virus invasion. Their findings appear in the April 24 ...
... Disease to Recovery Audits, Systemic Fiscal Reforms Needed, ... appeared headed toward a pre-Memorial Day showdown over ... 362,000-member,National Taxpayers Union (NTU) today offered a comprehensive ... fiscal foundation - without tax hikes or,price controls., ...
... 24 A multi-country,project called ACTwatch, which will ... will be launched in Nairobi,Friday -- World Malaria ... is,funded by a grant from the Bill & ... access to antimalarials, specifically,artemisinin-based combination therapies (ACTs), the ...
... by New Call Center, WASHINGTON, April 24 ... begin contacting nearly 570,000,recent combat veterans to ensure they ... will reach out and touch every veteran of Operation ... we are here for them,",said Dr. James B. Peake, ...
Cached Medicine News:Health News:Veterans Honor Dr. Richard Merkin During Research Week 2Health News:President Signs Elder Falls Bill Into Law 2Health News:Specialized white blood cells coordinate first responders to viral infection 2Health News:Taxpayer Group Offers Blueprint for Beating Medicare's Bankruptcy 2Health News:ACTwatch, to Improve Malaria Treatment, to Be Launched on World Malaria Day 2Health News:VA Calling All Recent Combat Vets 2
Inquire...
... Minifuge has an on/off switch which allows user ... improved safety. New hinge, with stainless steel pin ... work yet durable. Spins 6 microcentrifuge tubes at ... g). 6000rpm/2000 x g. 6 inch x 6 ...
Inquire...
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
Medicine Products: